SPI1 and cancer: Since pharmacological inhibition of glycolysis or knockdown of target genes abolished the oncogneic roles of SPI1 in tumourigenesis and aggressiveness, our results demonstrate that SPI1 promotes cancer progression through facilitating aerobic glycolysis of cancer cells.